Brookfield Wealth Solutions Ltd., through its subsidiaries, provides retirement services, wealth protection products, and capital solutions to individuals and institutions. It operates through Annuities, Property and Casualty (P&C), Life Insurance segments. The Annuities segment offers retail and institutional annuities, including fixed index, fixed rate, single premium immediate, and variable annuities, as well as pension risk transfer. The P&C segment provides property and specialty insurance products casualty insurance comprising specialty casualty, construction defect, general liability, commercial multi-peril, workers compensation, product and environmental liability, and auto liability. The Life Insurance segment offers whole life, universal life, and variable universal life insurance products. The company was formerly known as Brookfield Reinsurance Ltd. and changed its name to Brookfield Wealth Solutions Ltd. in September 2024. Brookfield Wealth Solutions Ltd. was incorporated in 2020 and is headquartered in Pembroke, Bermuda.

Brookfield Wealth Solutions Ltd. Class A Exchangeable Limited

In a report released today, Tristan Lamotte from Deutsche Bank maintained a Hold rating on Brenntag AG, with a price target of €46.00. According to...

Deutsche Bank  Keeps Their Hold Rating on Brenntag AG (0MPT)

In a report released yesterday, Harry Gillis from Berenberg Bank maintained a Buy rating on BioNTech SE, with a price target of $155.00. The compan...

BioNTech SE (BNTX) Gets a Buy from Berenberg Bank

In a report released yesterday, Geoff Meacham from Citi maintained a Buy rating on BioNTech SE, with a price target of $145.00. The company’s share...

Citi Sticks to Their Buy Rating for BioNTech SE (BNTX)

Berenberg Bank analyst Carl Raynsford maintained a Hold rating on Brenntag AG yesterday and set a price target of €48.00. The company’s shares clos...

Brenntag AG (0MPT) Receives a Hold from Berenberg Bank

BioNTech SE ( ($BNTX) ) has issued an announcement. On December 9, 2025, BioNTech SE and Bristol Myers Squibb announced interim results from a glob...

BioNTech and BMS Report Promising Phase 2 Results for TNBC Treatment

In a report released today, Chris Counihan from Jefferies maintained a Sell rating on Brenntag AG, with a price target of €42.00. According to TipR...

Jefferies Sticks to Its Sell Rating for Brenntag AG (0MPT)

BioNTech SE ( ($BNTX) ) has provided an update. On December 6, 2025, BioNTech SE and OncoC4, Inc. presented promising data from the non-pivotal dos...

BioNTech and OncoC4 Report Positive Phase 3 Trial Results for Gotistobart in Lung Cancer

BioNTech SE ( ($BNTX) ) has issued an update. On December 3, 2025, BioNTech SE announced that it has satisfied the minimum condition of its exchang...

BioNTech Satisfies Minimum Condition in CureVac Exchange Offer

Jefferies analyst Akash Tewari maintained a Buy rating on BioNTech SE today and set a price target of $151.00. Tewari covers the Healthcare sector,...

Jefferies Sticks to Their Buy Rating for BioNTech SE (BNTX)

Benitec Biopharma ( ($BNTC) ) has shared an update. On December 1, 2025, Benitec Biopharma Inc. held its virtual 2025 Annual Meeting of Stockholder...

Benitec Biopharma Concludes 2025 Annual Stockholders Meeting

Shares of major COVID-19 vaccine makers, Moderna ($MRNA), BioNTech ($BNTX), and Novavax ($NVAX) fell 6%, 5%, and 4%, respectively, on Monday. The d...

MRNA, NVAX, BNTX: Here’s What Triggered a Sell-off in Major Vaccine Stocks Today

J.P. Morgan analyst Chetan Udeshi maintained a Sell rating on Brenntag AG today and set a price target of €44.00. According to TipRanks, Udeshi is ...

J.P. Morgan Sticks to Their Sell Rating for Brenntag AG (0MPT)

BioNTech SE ( ($BNTX) ) has provided an announcement. On November 26, 2025, BioNTech SE announced the approval of its exchange offer for all outsta...

BioNTech Advances with CureVac Exchange Offer Approval

DZ BANK AG analyst Peter Spengler maintained a Sell rating on Brenntag AG yesterday. The company’s shares closed last Thursday at €49.17. According...

Brenntag AG (0MPT) Gets a Sell from DZ BANK AG

Kepler Capital analyst Martin Roediger maintained a Hold rating on Brenntag AG on November 12 and set a price target of €59.00. The company’s share...

Market Cap	$14.37B	P/E Ratio	NaN
52W High	$49.44	52W Low	$29.13
Div Yield	12.0%	Payout Ratio	0.0%
EPS Growth 3Y	N/A	52W Position	81.9%
Overall Score	74	Value Score	85
Quality Score	47	Technical Score	90

EPS Current Est	$NA	EPS Next Est	$NA
EPS Growth Est	N/A	DPS Growth 3Y	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	BNT	$45.77	-1.61%	53.07K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	BNT	$45.77	-1.6%	53.07K
3
4
5
6

BNT

BNT

Key Metrics Overview

Growth Analysis

Revenue (5Y)

EBITDA (5Y)

Get Brookfield Wealth Solutions Ltd. Class A Exchangeable Limited Data in Excel

Get Brookfield Wealth Solutions Ltd. Class A Exchangeable Limited Data in Excel